CCL2 binding is CCR2 independent in primary adult human astrocytes

Brain Research

Volumn 1437, Issue , 2012, Pages 115-126

  Fouillet, A ^a,b   Mawson, J ^a   Suliman, O ^a,c   Sharrack, B ^c   Romero, I A ^b   Woodroofe, M N ^a  

^a SHEFFIELD HALLAM UNIVERSITY   (United Kingdom)

^b OPEN UNIVERSITY   (United Kingdom)

^c SHEFFIELD TEACHING HOSPITALS NHS FOUNDATION TRUST   (United Kingdom)

Author keywords

Astrocyte; CCL2 CCR2; D6 decoy receptor; Inflammation; Multiple sclerosis

Indexed keywords

CHEMOKINE RECEPTOR; CHEMOKINE RECEPTOR CCR2; D6 CHEMOKINE DECOY RECEPTOR; MESSENGER RNA; MONOCYTE CHEMOTACTIC PROTEIN 1; PROTEIN; UNCLASSIFIED DRUG;

ADULT; ARTICLE; ASTROCYTE; BINDING SITE; CELL MIGRATION; CELL TYPE; CONTROLLED STUDY; HUMAN; HUMAN CELL; PRIORITY JOURNAL; PROTEIN BINDING; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN LOCALIZATION; PROTEIN PHOSPHORYLATION; PROTEIN PROTEIN INTERACTION; REGULATORY MECHANISM;

ADULT; ASTROCYTES; CELLS, CULTURED; CHEMOKINE CCL2; HUMANS; INFLAMMATION MEDIATORS; PROTEIN BINDING; RECEPTORS, CCR10; RECEPTORS, CCR2;

EID: 84856253422     PISSN: 00068993     EISSN: 18726240     Source Type: Journal    
DOI: 10.1016/j.brainres.2011.11.049     Document Type: Article

References (63)

1. G. Androdias Meningeal T cells associate with diffuse axonal loss in multiple sclerosis spinal cords Ann. Neurol. 68 2010 465 476
2. I. Banisor Involvement of beta-chemokines in the development of inflammatory demyelination J. Neuroinflammation 2 2005 7
3. P.E. Blackburn Purification and biochemical characterization of the D6 chemokine receptor Biochem. J. 379 2004 263 272 (Pubitemid 38570098)
4. R. Bonecchi Differential recognition and scavenging of native and truncated macrophage-derived chemokine (macrophage-derived chemokine/CC chemokine ligand 22) by the D6 decoy receptor J. Immunol. 172 2004 4972 4976 (Pubitemid 38456423)
5. E.M. Borroni The chemoattractant decoy receptor D6 as a negative regulator of inflammatory responses Biochem. Soc. Trans. 34 2006 1014 1017 (Pubitemid 46768979)
6. E. Brylla Coexpression of preprotachykinin A and B transcripts in the bovine corpus luteum and evidence for functional neurokinin receptor activity in luteal endothelial cells and ovarian macrophages Regul. Pept. 125 2005 125 133 (Pubitemid 39593717)
7. L. Cartier Chemokine receptors in the central nervous system: role in brain inflammation and neurodegenerative diseases Brain Res. Rev. 48 2005 16 42 (Pubitemid 40215781)
8. A. Compston, and A. Coles Multiple sclerosis Lancet 372 2008 1502 1517
9. G. Conductier The role of monocyte chemoattractant protein MCP1/CCL2 in neuroinflammatory diseases J. Neuroimmunol. 2010 2010 5
10. J. Croitoru-Lamoury Expression of chemokines and their receptors in human and simian astrocytes: evidence for a central role of TNF alpha and IFN gamma in CXCR4 and CCR5 modulation Glia 41 2003 354 370 (Pubitemid 36314149)
11. D. Di Liberto Role of the chemokine decoy receptor D6 in balancing inflammation, immune activation, and antimicrobial resistance in Mycobacterium tuberculosis infection J. Exp. Med. 205 2008 2075 2084
12. A.C. dos Santos CCL2 and CCL5 mediate leukocyte adhesion in experimental autoimmune encephalomyelitis-an intravital microscopy study J. Neuroimmunol. 162 2005 122 129
13. B. Engelhardt Molecular mechanisms involved in T cell migration across the blood-brain barrier J. Neural Transm. 113 2006 477 485
14. B. Engelhardt, and R.M. Ransohoff The ins and outs of T-lymphocyte trafficking to the CNS: anatomical sites and molecular mechanisms Trends Immunol. 26 2005 485 495 (Pubitemid 41139258)
15. G. Flynn Regulation of chemokine receptor expression in human microglia and astrocytes J. Neuroimmunol. 136 2003 84 93 (Pubitemid 36298847)
16. A.M. Fra Cutting edge: scavenging of inflammatory CC chemokines by the promiscuous putatively silent chemokine receptor D6 J. Immunol. 170 2003 2279 2282 (Pubitemid 36245612)
17. S.N. Giraud Estradiol inhibits ongoing autoimmune neuroinflammation and NFkappaB-dependent CCL2 expression in reactive astrocytes Proc. Natl. Acad. Sci. U. S. A. 107 2010 8416 8421
18. J. Gosling Cutting edge: identification of a novel chemokine receptor that binds dendritic cell- and T cell-active chemokines including ELC, SLC, and TECK J. Immunol. 164 2000 2851 2856 (Pubitemid 30148939)
19. M. Heesen Mouse astrocytes respond to the chemokines MCP-1 and KC, but reverse transcriptase-polymerase chain reaction does not detect mRNA for the KC or new MCP-1 receptor J. Neurosci. Res. 45 1996 382 391 (Pubitemid 26299593)
20. D.R. Huang Absence of monocyte chemoattractant protein 1 in mice leads to decreased local macrophage recruitment and antigen-specific T helper cell type 1 immune response in experimental autoimmune encephalomyelitis J. Exp. Med. 193 2001 713 726
21. H. Jung Visualization of chemokine receptor activation in transgenic mice reveals peripheral activation of CCR2 receptors in states of neuropathic pain J. Neurosci. 29 2009 8051 8062
22. A.N. Kalehua Monocyte chemoattractant protein-1 and macrophage inflammatory protein-2 are involved in both excitotoxin-induced neurodegeneration and regeneration Exp. Cell Res. 297 2004 197 211 (Pubitemid 38759573)
23. K.J. Kennedy Acute and relapsing experimental autoimmune encephalomyelitis are regulated by differential expression of the CC chemokines macrophage inflammatory protein-1alpha and monocyte chemotactic protein-1 J. Neuroimmunol. 92 1998 98 108 (Pubitemid 29015994)
24. M.O. Kim Regulation of RANTES/CCL5 expression in human astrocytes by interleukin-1 and interferon-beta J. Neurochem. 90 2004 297 308
25. L. Liu Cutting edge: the silent chemokine receptor D6 is required for generating T cell responses that mediate experimental autoimmune encephalomyelitis J. Immunol. 177 2006 17 21 (Pubitemid 43939108)
26. K.J. Livak, and T.D. Schmittgen Analysis of relative gene expression data using real-time quantitative PCR and the 2(- Delta Delta C(T)) Method Methods 25 2001 402 408 (Pubitemid 34164012)
27. M. Locati Silent chemoattractant receptors: D6 as a decoy and scavenger receptor for inflammatory CC chemokines Cytokine Growth Factor Rev. 16 2005 679 686 (Pubitemid 41505523)
28. D.J. Mahad, and R.M. Ransohoff The role of MCP-1 (CCL2) and CCR2 in multiple sclerosis and experimental autoimmune encephalomyelitis (EAE) Semin. Immunol. 15 2003 23 32 (Pubitemid 36092176)
29. D.J. Mahad Expression of chemokines in the CSF and correlation with clinical disease activity in patients with multiple sclerosis J. Neurol. Neurosurg. Psychiatry 72 2002 498 502
30. D. Mahad Modulating CCR2 and CCL2 at the blood-brain barrier: relevance for multiple sclerosis pathogenesis Brain 129 2006 212 223 (Pubitemid 43063772)
31. A. Mantovani Decoy receptors: a strategy to regulate inflammatory cytokines and chemokines Trends Immunol. 22 2001 328 336 (Pubitemid 32675247)
32. A. Mantovani Tuning inflammation and immunity by chemokine sequestration: decoys and more Nat. Rev. Immunol. 6 2006 907 918 (Pubitemid 44851733)
33. Y. Martinez de la Torre Increased inflammation in mice deficient for the chemokine decoy receptor D6 Eur. J. Immunol. 35 2005 1342 1346
34. Y. Martinez de la Torre Protection against inflammation- and autoantibody-caused fetal loss by the chemokine decoy receptor D6 Proc. Natl. Acad. Sci. U. S. A. 104 2007 2319 2324
35. C.S. McKimmie, and G.J. Graham Astrocytes modulate the chemokine network in a pathogen-specific manner Biochem. Biophys. Res. Commun. 394 2010 1006 1011
36. C. McManus MCP-1, MCP-2 and MCP-3 expression in multiple sclerosis lesions: an immunohistochemical and in situ hybridization study J. Neuroimmunol. 86 1998 20 29 (Pubitemid 28293946)
37. M. Mellado Chemokine receptor homo- or heterodimerization activates distinct signaling pathways EMBO J. 20 2001 2497 2507 (Pubitemid 32452868)
38. A. Minagar, and J.S. Alexander Blood-brain barrier disruption in multiple sclerosis Mult. Scler. 9 2003 540 549 (Pubitemid 37479401)
39. A. Minagar The role of macrophage/microglia and astrocytes in the pathogenesis of three neurologic disorders: HIV-associated dementia, Alzheimer disease, and multiple sclerosis J. Neurol. Sci. 202 2002 13 23 (Pubitemid 36153117)
40. B. Moser Chemokines: multiple levels of leukocyte migration control Trends Immunol. 25 2004 75 84 (Pubitemid 38167488)
41. K. Neote Functional and biochemical analysis of the cloned Duffy antigen: identity with the red blood cell chemokine receptor Blood 84 1994 44 52 (Pubitemid 24193803)
42. R.J. Nibbs Cloning and characterization of a novel promiscuous human beta-chemokine receptor D6 J. Biol. Chem. 272 1997 32078 32083 (Pubitemid 28011878)
43. R.J. Nibbs The beta-chemokine receptor D6 is expressed by lymphatic endothelium and a subset of vascular tumors Am. J. Pathol. 158 2001 867 877 (Pubitemid 32221780)
44. M.W. Pfaffl A new mathematical model for relative quantification in real-time RT-PCR Nucleic Acids Res. 29 2001 e45
45. A.E. Proudfoot Glycosaminoglycan binding and oligomerization are essential for the in vivo activity of certain chemokines Proc. Natl. Acad. Sci. U. S. A. 100 2003 1885 1890 (Pubitemid 36254543)
46. R.M. Ransohoff Chemokines and chemokine receptors: standing at the crossroads of immunobiology and neurobiology Immunity 31 2009 711 721
47. J. Saas Molecular phenotyping of HCS-2/8 cells as an in vitro model of human chondrocytes Osteoarthr. Cartil. 12 2004 924 934 (Pubitemid 39462608)
48. N. Saederup Selective chemokine receptor usage by central nervous system myeloid cells in CCR2-red fluorescent protein knock-in mice PLoS 5 2010 e13693
49. M. Sato Glycosaminoglycan accumulation in primary culture of rabbit intervertebral disc cells Spine 26 2001 2653 2660 (Pubitemid 34019750)
50. E. Scarpini IP-10 and MCP-1 levels in CSF and serum from multiple sclerosis patients with different clinical subtypes of the disease J. Neurol. Sci. 195 2002 41 46 (Pubitemid 34175097)
51. J.E. Simpson Expression of monocyte chemoattractant protein-1 and other beta-chemokines by resident glia and inflammatory cells in multiple sclerosis lesions J. Neuroimmunol. 84 1998 238 249 (Pubitemid 28248412)
52. J. Simpson Expression of the beta-chemokine receptors CCR2, CCR3 and CCR5 in multiple sclerosis central nervous system tissue J. Neuroimmunol. 108 2000 192 200 (Pubitemid 30438767)
53. J.E. Simpson Expression of the interferon-gamma-inducible chemokines IP-10 and Mig and their receptor, CXCR3, in multiple sclerosis lesions Neuropathol. Appl. Neurobiol. 26 2000 133 142 (Pubitemid 30251386)
54. M. Sospedra, and R. Martin Immunology of multiple sclerosis Annu. Rev. Immunol. 23 2005 683 747 (Pubitemid 40563183)
55. S.M. Stamatovic Potential role of MCP-1 in endothelial cell tight junction 'opening': signaling via Rho and Rho kinase J. Cell Sci. 116 2003 4615 4628 (Pubitemid 37461616)
56. L. Steinman Nuanced roles of cytokines in three major human brain disorders J. Clin. Invest. 118 2008 3557 3563
57. N. Tanuma Chemokine expression by astrocytes plays a role in microglia/macrophage activation and subsequent neurodegeneration in secondary progressive multiple sclerosis Acta Neuropathol. (Berl.) 112 2006 195 204
58. D.J. Turner Substance P regulates migration in rat intestinal epithelial cells Ann. Surg. 245 2007 408 414 (Pubitemid 46673137)
59. S. van Neerven Inflammatory chemokine release of astrocytes in vitro is reduced by all-trans retinoic acid J. Neurochem. 114 2010 1511 1526
60. M. Weber The chemokine receptor D6 constitutively traffics to and from the cell surface to internalize and degrade chemokines Mol. Biol. Cell 15 2004 2492 2508 (Pubitemid 38580663)
61. G.S. Whitehead The chemokine receptor D6 has opposing effects on allergic inflammation and airway reactivity Am. J. Respir. Crit. Care Med. 175 2007 243 249 (Pubitemid 46203127)
62. S. Youssef Prevention of experimental autoimmune encephalomyelitis by MIP-1alpha and MCP-1 naked DNA vaccines J. Autoimmun. 13 1999 21 29 (Pubitemid 29367003)
63. T. Zhang Migration of cytotoxic T lymphocytes toward melanoma cells in three-dimensional organotypic culture is dependent on CCL2 and CCR4 Eur. J. Immunol. 36 2006 457 467 (Pubitemid 43257469)